
Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study
Author(s) -
Bernhard T. Baune,
Ioana Florea,
Bjarke Ebert,
Maëlys Touya,
Anders Ettrup,
M. Abdel Hadi,
Hongye Ren
Publication year - 2021
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s325954
Subject(s) - medicine , escitalopram , major depressive disorder , antidepressant , sertraline , psychiatry , anxiety , quality of life (healthcare) , sadness , panic disorder , depression (economics) , venlafaxine , bupropion , clinical psychology , mood , anger , economics , pathology , smoking cessation , nursing , macroeconomics
This qualitative study explored patient perceptions of the most burdensome symptoms of major depressive disorder (MDD), the impact of symptoms on patients' daily lives, and patient expectations and experiences regarding the timing of onset of antidepressant pharmacotherapy.